Cargando…
Yttrium-90 radioembolization for colorectal cancer liver metastases: a prospective cohort study on circulating angiogenic factors and treatment response
BACKGROUND: Yttrium-90 radioembolization ((90)Y-RE) as a treatment for liver tumours induces radiation damage and hypoxia in liver tissue, which is also a trigger for systemic release of angiogenic factors, potentially stimulating tumour growth. We examined changes in circulating angiogenic factors...
Autores principales: | Rosenbaum, C. E. N. M., van den Hoven, A. F., Braat, M. N. G. J. A., Koopman, M., Lam, M. G. E. H., Zonnenberg, B. A., Verkooijen, H. M., van den Bosch, M. A. A. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5177600/ https://www.ncbi.nlm.nih.gov/pubmed/28004357 http://dx.doi.org/10.1186/s13550-016-0236-1 |
Ejemplares similares
-
Clinical and Laboratory Toxicity after Intra-Arterial Radioembolization with (90)Y-Microspheres for Unresectable Liver Metastases
por: Smits, Maarten L. J., et al.
Publicado: (2013) -
Correction: Clinical and Laboratory Toxicity after Intra-Arterial Radioembolization with (90)Y-Microspheres for Unresectable Liver Metastases
por: Smits, Maarten L. J., et al.
Publicado: (2013) -
Technical Solutions to Ensure Safe Yttrium-90 Radioembolization in Patients With Initial Extrahepatic Deposition of (99m)Technetium–Albumin Macroaggregates
por: Barentsz, M. W., et al.
Publicado: (2010) -
Verification Study of Residual Activity Measurements After Yttrium-90 Radioembolization with Glass Microspheres
por: Ebbers, S. C., et al.
Publicado: (2020) -
The role of (90)Y-radioembolization in downstaging primary and secondary hepatic malignancies: a systematic review
por: Braat, M. N. G. J. A., et al.
Publicado: (2016)